top of page
1645180177939.jpg

WELMO

​Wearable Electronics for Effective Lung Monitoring

About the project:

Start: 1st Gen 2019.
UE funding: 3.999.675 €
Coordinator: EXODUS ANONYMOS ETAIREIA PLIROFORIKIS (Greece).

welmo-01.jpg

WELMO aims at developing and validating a new generation of low-cost and low-power miniaturized sensors, integrated in a comfortable vest, enabling the effective and accurate monitoring of the lungs, through the simultaneous collection of sound and electrical impedance tomography (EIT) signals with the same sensors that can be combined, processed and linked with specific clinical outcomes making the systematic, accurate and real-time evaluation of respiratory conditions possible.

The diagnosis, monitoring and treatment of lung diseases depend on the availability of a variety of medical products.
These include devices such as stethoscopes, blood gas analysis systems, spirometers, MRIs and functional imaging methods (EIT) that are discontinuously used both in the diagnosis and monitoring of the lung disease progression and treatment. The common drawbacks of all the stated examination methods are that they are not portable and only allow a momentary patient assessment at the time point of out-clinic visit or hospitalization.

Results:

WELMO’s main goal is to develop, test, validate and commercialise a fully integrated proactive and personalised technology solution, providing 360° data from clinician, patient and external inputs. The technology solution combines a smart vest including sensors which measure and monitor specific COPD patient indicators. Combined with other personalised patient and environmental information, real-time data can be automatically uploaded to highly secure cloud-based patient medical records. From this hub, patients, clinicians and community health professionals can better monitor and manage integrated personalised care plans.

Further information on WELMO:

Follow WELMO:

  • Facebook
  • Twitter
bottom of page